Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
6.66
-0.17 (-2.49%)
Sep 11, 2026, 3:04 PM CST

SHE:300253 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,5931,7621,3361,1141,2821,601
Trading Asset Securities
--3---
Cash & Short-Term Investments
1,5931,7621,3391,1141,2821,601
Cash Growth
19.44%31.60%20.18%-13.07%-19.92%56.06%
Accounts Receivable
2,7572,8723,3793,3422,6932,215
Other Receivables
80.3599.43131.88158.13135.25151.35
Receivables
2,8372,9723,5113,5002,8292,366
Inventory
101.8100.3111.11110.7497.5133.09
Prepaid Expenses
0.882.421.122.121.021.18
Other Current Assets
74.1288.55132.85126.7102.7374.16
Total Current Assets
4,6074,9255,0954,8544,3124,175
Property, Plant & Equipment
470.21479.18492.9508.88528.86540.99
Long-Term Investments
858.11870.87898.69946.76960.56993.46
Goodwill
409.9409.9497.59589.62596.23637.95
Other Intangible Assets
1,3401,4471,1061,037505.43940.32
Long-Term Accounts Receivable
12.9312.8717.5621.8229.5718.38
Long-Term Deferred Tax Assets
307.27268.44193.18214.34205.47177.19
Long-Term Deferred Charges
193.15109.96455.74377.01684.0313.12
Total Assets
8,1998,5238,7568,5497,8227,496

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
638.71672.67697.53674.69602.97499.25
Accrued Expenses
316.54363.98425.47480.9400.78286.33
Short-Term Debt
14.5115.0640.2958.0342.86-
Current Portion of Long-Term Debt
1,13313.8811.577.733.872.26
Current Portion of Leases
5.688.3313.5612.8715.0513.83
Current Income Taxes Payable
3.857.916.465.1257.2155.03
Current Unearned Revenue
259.71270.65141.3144.68194.26202.83
Other Current Liabilities
277.15387.19299.45263.74265.42214.24
Total Current Liabilities
2,6491,7401,6461,7081,5821,274
Long-Term Debt
-1,1021,0521,002950.5898.24
Long-Term Leases
12.3411.5713.7617.6224.222.15
Long-Term Unearned Revenue
1.171.541.351.742.32.29
Long-Term Deferred Tax Liabilities
38.7338.7339.0739.0670.8373.47
Other Long-Term Liabilities
28.8234.5671.1599.6464.7352.97
Total Liabilities
2,7302,9282,8232,8682,6952,323

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
2,2012,2162,1912,1522,1482,146
Additional Paid-In Capital
1,0471,0811,063871.65635.69572.22
Retained Earnings
2,1432,3192,7262,6812,3442,278
Treasury Stock
--120.64-120.64-120.64-120.64-
Comprehensive Income & Other
91.791.7102.91102.91102.92102.93
Total Common Equity
5,4825,5865,9625,6875,1105,100
Minority Interest
-13.439.19-27.95-5.8116.8473.46
Shareholders' Equity
5,4695,5965,9345,6815,1275,173
Total Liabilities & Equity
8,1998,5238,7568,5497,8227,496

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,1651,1501,1311,0981,036936.48
Net Cash (Debt)
427.82611.59207.8315.99245.18664.07
Net Cash Growth
94.35%194.27%1199.84%-93.48%-63.08%-18.20%
Net Cash Per Share
0.190.280.100.010.110.31
Filing Date Shares Outstanding
2,2012,2012,1982,1452,1332,146
Total Common Shares Outstanding
2,2012,2012,1772,1382,1332,146
Working Capital
1,9583,1853,4503,1462,7292,901
Book Value Per Share
2.492.542.742.662.402.38
Tangible Book Value
3,7323,7294,3594,0614,0083,522
Tangible Book Value Per Share
1.701.692.001.901.881.64
Buildings
517.82517.82517.82517.82517.03517.03
Machinery
75.3373.969.2966.0360.758.44
Construction In Progress
-----1.29